Reducing Surprise From Out-of-Network Bills
In a recent report, researchers advocate limits to the fees that out-of-network health care providers can charge.
Regulating the Use of Genetic Information
Scholar advocates expanding federal legal protections against genetic discrimination.
Using Subjective Evidence in FDA Review
Scholars call for greater transparency in how FDA uses subjective evidence in treatments for brain injuries.
Regulating Complaints in Human Subjects Research
Scholar examines the institutional review board process for resolving disputes in human subjects research.
Regulating Rationing During the COVID-19 Crisis
Regulators and policymakers review old rules and propose new guidelines for rationing ventilators.
Encouraging Competition Through Generic Drugs
FDA clarifies its generic drug approval process in an effort to encourage market competition.
Resolving Regulatory Confusion Over Medical Software
FDA clarifies enforcement priorities for medical device clinical decision support software.
Drug Approval During a Public Health Crisis
FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.
Determining the Safety of CBD Products
FDA warns consumers that the agency has not evaluated most CBD products and cannot say they are safe.
Promoting Primary Care in Medicine
Experts suggest changing Medicare’s payment structure to encourage physicians to pursue primary care specialties.
Human Milk Markets Need Regulation
Scholar says that human milk should be regulated to ensure donor milk is safe, accessible, and affordable.
More Regulation Needed to Combat Risks From Cosmetics
Scholar argues that the association between cosmetics and femininity has contributed to harmful under-regulation.